Companies: 10,795·Total market cap: $144.5T
NetMed, Inc.

NetMed, Inc.

NTMEOTCFinancial Services
$0.00
+$0.00(+0.00%)
Market Cap$140
P/E Ratio
52W High$0.00001
52W Low$0.00001

NetMed, Inc. (NTME) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ntme · pe ratio · data through Dec 31, 2001

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for NetMed, Inc. (NTME) measures how much investors pay for each dollar of the company's trailing earnings. NTME's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2001-12-31

Forward P/E
N/A
EPS (TTM)
-$0.02
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NetMed, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

1996 – 2001 · Annual
PE Ratio (TTM)
5Y Avg 0.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Asset Management · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
NetMed, Inc.
NetMed, Inc.You
NTME
$0MN/A-$0.02
American Business Corp.
American Business Corp.
ARBU
$0MN/A-$4.19
Beneficial Holdings, Inc.
Beneficial Holdings, Inc.
BFHJ
$0MN/A-$0.21
Cascadia Investments, Inc.
Cascadia Investments, Inc.
CDIV
$0M240.64x+98.0%$0.00
Detwiler Fenton Group, Inc.
Detwiler Fenton Group, Inc.
DMCD
$0M2.37x-98.0%$0.38
GIB Capital Group, Inc.
GIB Capital Group, Inc.
GIBX
$0MN/A-$0.03
In Veritas Medical Diagnostics, Inc.
In Veritas Medical Diagnostics, Inc.
IVMED
$0MN/A-$0.00
Industry Average
2 peers with valid PE
121.50xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2001-12-31Latest
FY2001
$-0.02
2000-12-31
FY2000
0.59x$0.06
1999-12-31
FY1999
$-0.05
1998-12-31
FY1998
$-0.23
1997-12-31
FY1997
$-0.30
1996-12-31
FY1996
$-0.05

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for NetMed, Inc. (NTME) measures how much investors pay for each dollar of the company's trailing earnings. NTME's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.02.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.02 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NTME pe ratio · 6 questions

NTME's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via NTME's SEC 10-K and 10-Q filings.

NTME PE ratioWhat is NTME PE ratioCurrent PE ratio of NTMENTME PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NetMed, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09